webinar register page

Webinar banner
NeoGenomics Diagnostic Symposium: New Developments in Leukemia
Join us for our Heme Diagnostic Symposium to learn from industry-leading experts during this one hour session, “New Developments in Leukemia”
FEATURING: Daniel A. Arber, MD; Chair of Pathology and Donald West and Mary Elizabeth King Professor of Pathology, The University of Chicago

HOSTED BY: Derek Lyle, MD; Medical Director, NeoGenomics

Apr 20, 2021 12:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information
Loading

By registering, I agree to the Privacy Statement and Terms of Service.

Register

Speakers

Daniel A. Arber, MD
Donald West and Mary Elizabeth King Professor and Chair of Pathology @University of Chicago
Dr. Arber specializes in the diagnosis of leukemia, lymphoma and splenic tumors. His primary research interests are the development of prognostically significant classification systems of hematopoietic tumors and the study of acquired genetic changes in leukemia and lymphoma. Dr. Arber has authored or co-authored over 300 peer-reviewed journal articles, chapters, and reviews, has written/edited ten medical text books and is on the editorial board of seven major pathology journals. He is the pathologist for the Eastern Cooperative Oncology Group Leukemia Committee and was a senior advisor for the 2016 WHO Classification of hematopoietic tumors and a co-author of the NCCN guidelines for the treatment of acute myeloid leukemia. He has held positions as co-chair of the ASH/CAP Expert Panel on Acute Leukemia Workup Guidelines and president of the Society for Hematopathology and Board of Directors for the US & Canadian Academy of Pathology.
Derek Lyle, MD
Medical Director (Fort Myers, Florida and Carlsbad, California) @NeoGenomics Laboratories
Dr. Lyle joined NeoGenomics in 2018. Before joining NeoGenomics, Dr. Lyle worked at Genoptix Medical Laboratory for 9 years, where he initially served as Director of Hematopathology and, later, as Medical Director and Chief Medical Officer. Prior to joining Genoptix, Dr. Lyle worked as a surgical pathologist in Palm Springs, CA. Dr. Lyle completed combined Anatomic Pathology and Clinical Pathology residency training at Cedars-Sinai Medical Center in Los Angeles, CA, where he served as Chief Resident, and a Hematopathology fellowship at City of Hope National Medical Center. He is board-certified in Anatomic Pathology, Clinical Pathology, and Hematopathology. In addition to diagnostic hematopathology, Dr. Lyle’s areas of interest include surgical pathology and molecular profiling of solid tumors and hematopoietic neoplasms. Dr. Lyle is a member of several professional organizations, including College of American Pathologists where he serves as an Inspection Team Leader.